Toxoplasma gondii induces the secretion of monocyte chemotactic protein-1 in human fibroblasts, in vitro

Mol Cell Biochem. 2000 Jun;209(1-2):79-87. doi: 10.1023/a:1007075701551.

Abstract

Secretion of Monocyte Chemotactic Protein-1 (MCP-1) by fibroblasts infected with Toxoplasma gondii was studied in vitro. A significantly higher MCP-1 secretion was observed 24 h after infection by live tachyzoites. Analysis of chemokine mRNA transcripts by RNase protection assay revealed that this MCP-1 secretion seems associated with increased MCP-1 mRNA expression. However, these increased levels of MCP-1 secretion and expression were not obtained after stimulation by heat-killed tachyzoites or parasites pre-treated by a specific inhibitor of phosphatidylcholine-specific phospholipase C (D609). Inhibition of parasite multiplication by pyrimethamine did not modify MCP-1 secretion. Thus, it appeared that the active penetration of T. gondii in cells was of major importance in the induction of MCP-1 secretion. None of the other chemokines studied by RNase protection assay (lymphotactin, RANTES, IP-10, MIP-1alpha, MIP-1beta, IL-8, and I-309) were expressed after infection by live tachyzoites. We also found that MCP-1 secretion induced by live T. gondii is blocked by inhibitors of nuclear factor (NF)-kappaB activation, ALLN and MG132. Such data indicate that NF-kappaB could be involved in T. gondii-induced MCP-1 production. MCP-1 secretion may contribute to the recruitment of monocytes and lymphocytes and thus participate in the control of T. gondii infection and in its pathogenesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antiprotozoal Agents / pharmacology
  • Bridged-Ring Compounds / pharmacology
  • Cells, Cultured
  • Chemokine CCL2 / genetics
  • Chemokine CCL2 / metabolism*
  • Chemokines / genetics
  • Enzyme Inhibitors / pharmacology
  • Fibroblasts / drug effects
  • Fibroblasts / parasitology*
  • Fibroblasts / physiology*
  • Gene Expression Regulation
  • Humans
  • Kinetics
  • Leupeptins / pharmacology
  • Mice
  • Norbornanes
  • Proline / analogs & derivatives
  • Proline / pharmacology
  • Pyrimethamine / pharmacology
  • Thiocarbamates / pharmacology
  • Thiones / pharmacology
  • Time Factors
  • Toxoplasma / drug effects
  • Toxoplasma / physiology*
  • Transcription, Genetic
  • Type C Phospholipases / antagonists & inhibitors

Substances

  • Antiprotozoal Agents
  • Bridged-Ring Compounds
  • Chemokine CCL2
  • Chemokines
  • Enzyme Inhibitors
  • Leupeptins
  • Norbornanes
  • Thiocarbamates
  • Thiones
  • prolinedithiocarbamate
  • tricyclodecane-9-yl-xanthogenate
  • Proline
  • Type C Phospholipases
  • benzyloxycarbonylleucyl-leucyl-leucine aldehyde
  • Pyrimethamine